Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Vaccine
Sort By
Newest First
1 / 7
Intravacc
GMP
Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur
Intravacc
PR-M03-22-09
Mar 22, 2022
Araclon Biotech
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06
Mar 15, 2022
Poolbeg Pharma PLC
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22
Jan 31, 2022
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
PR-M06-21-024
Jun 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01
Jun 04, 2021
Vaxxas
Vaccine
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Vaxxas
PR-M06-21-006
Jun 04, 2021
Samsung Biologics
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
Samsung Biologics
PR-M05-21-016
May 25, 2021
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-03
May 17, 2021
DNA Script
Partnership
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
DNA Script
PR-M04-21-029
Apr 29, 2021
Immunity
The Link Between COVID-19 and Immunity
Dr. Andrew Myers
PTV-04-21-CL-003
Apr 28, 2021
Sanofi
Manufacturing
Sanofi to Invest in Vaccine Production Site in Singapore
Sanofi
PR-M04-21-011
Apr 13, 2021
Valneva SE
Vaccine
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Valneva SE
PR-M04-21-006
Apr 08, 2021
UBC
COVID-19 Vaccine
UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation
UBC
PR-M11-20-046
Mar 09, 2021
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Rentschler Biopharma SE
PAP-Q4-20-CL-028
Dec 09, 2020
COVID-19 Impacts
Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
Pharma's Almanac
PAP-Q4-20-NI-006
Dec 09, 2020
The Russian Direct Investment Fund (RDIF)
COVID-19 Vaccine
Russia's Sputnik V COVID-19 Vaccine Is 91% Effective
The Russian Direct Investment Fund (RDIF)
PR-M11-20-023-1178
Nov 24, 2020
Moderna
COVID-19 Vaccine
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna
PR-M11-20-013
Nov 16, 2020
Moderna
Cancer Vaccine
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
Moderna
PR-M11-20-009
Nov 11, 2020
Novavax
Fast Track
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax
PR-M11-20-008
Nov 10, 2020
GSK
COVID-19 Vaccine
Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine
GSK
PR-M10-20-18
Oct 28, 2020
1 / 7
